Latest News
Conference Coverage
Treating LDL to below 70 reduces recurrent stroke
PHILADELPHIA – Results of TST, a rare cholesterol study in patients with a history of ischemic stroke, explore the benefits of treating to a lower...
Feature
Open enrollment 2020: Activity down on Healthcare.gov
Consumers choose fewer plans during week 3, compared with last week and last year.
News from the FDA/CDC
FDA approves Givlaari for treatment of acute hepatic porphyria
Prior to this approval, existing treatments provided only partial relief from porphyria attacks, according to the FDA.
Literature Review
Benefits of focused ultrasound thalamotomy for essential tremor persist for 3 years
Patients who undergo the procedure appear not to have progressive or delayed complications during long-term follow-up.
FDA/CDC
Vaping front and center at Hahn’s first FDA confirmation hearing
Stephen Hahn, MD, President Trump’s pick to head the Food and Drug Administration, faced questions from both sides of the aisle on youth vaping,...
From the Journals
Ubrogepant may relieve migraine pain at 2 hours
More patients who received the oral CGRP receptor antagonist were free of pain 2 hours later, compared with patients who received placebo,...
From the Journals
Alzheimer’s disease subtypes follow neuropathologic patterns seen in the nucleus basalis of Meynert
From the Journals
Rand analysis of proposed Medicare buy-in uncovers surprising findings
“When older adults leave the market, insurers are left with a smaller pool of younger, less healthy, and relatively expensive people given their...
Conference Coverage
Children may develop prolonged headache after concussion
CHARLOTTE, N.C. – Headache after pediatric concussion may present as migraine, chronic daily headache, tension-type...
Conference Coverage
AVXS-101 may result in long-term motor improvements in SMA
CHARLOTTE, N.C. – Data indicate continuous expression of the SMN protein among treated patients.
Conference Coverage
POTS heterogeneity requires individualized treatment
AUSTIN, TEX. – Despite an increasing awareness of its prevalence, POTS often still goes unrecognized and requires a therapeutic approach that...